Fecal hemoglobin concentration is useful for risk stratification of advanced colorectal neoplasia

Digestive and Liver Disease

Volumn 48, Issue 6, 2016, Pages 667-672

  Kim, Nam Hee ^a   Kwon, Min Jung ^a   Kim, Hyun Young ^a   Lee, Taeheon ^a   Jeong, Seok Hyeon ^a   Park, Dong Il ^a   Choi, Kyuyong ^a   Jung, Yoon Suk ^a  

^a School of Medicine   (South Korea)

Author keywords

Advanced colorectal neoplasia; Quantitative fecal immunochemical test; Risk factors

Indexed keywords

HEMOGLOBIN;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; COLONOSCOPE; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL TUMOR; FECAL HEMOGLOBIN CONCENTRATION; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; GENDER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; ODDS RATIO; PROCEDURES; RISK FACTOR; SOUTH KOREA; STATISTICAL MODEL;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HEMOGLOBINS; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; OCCULT BLOOD; ODDS RATIO; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 84961262556     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2016.03.001     Document Type: Article

References (29)

1. Lin O.S., Kozarek R.A., Cha J.M. Impact of sigmoidoscopy and colonoscopy on colorectal cancer incidence and mortality: an evidence-based review of published prospective and retrospective studies. Intestinal Research 2014, 12:268-274.
2. Inra J.A., Syngal S. Colorectal cancer in young adults. Digestive Diseases and Sciences 2015, 60:722-733.
3. Cha J.M. Colonoscopy quality is the answer for the emerging issue of interval cancer. Intestinal Research 2014, 12:110-116.
4. Kim E.R., Kim Y.H. Clinical application of genetics in management of colorectal cancer. Intestinal Research 2014, 12:184-193.
5. Levin B., Lieberman D.A., McFarland B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA: A Cancer Journal for Clinicians 2008, 58:130-160.
6. Young G.P., Symonds E.L., Allison J.E., et al. Advances in fecal occult blood tests: the FIT revolution. Digestive Diseases and Sciences 2015, 60:609-622.
7. Whitlock E.P., Lin J.S., Liles E., et al. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2008, 149:638-658.
8. Park D.I., Ryu S., Kim Y.H., et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. American Journal of Gastroenterology 2010, 105:2017-2025.
9. Guittet L., Bouvier V., Mariotte N., et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007, 56:210-214.
10. van Rossum L.G., van Rijn A.F., Laheij R.J., et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008, 135:82-90.
11. Dancourt V., Lejeune C., Lepage C., et al. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. European Journal of Cancer 2008, 44:2254-2258.
12. Digby J., Fraser C.G., Carey F.A., et al. Faecal haemoglobin concentration is related to severity of colorectal neoplasia. Journal of Clinical Pathology 2013, 66:415-419.
13. Rozen P., Levi Z., Hazazi R., et al. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed. Alimentary Pharmacology and Therapeutics 2009, 29:906-917.
14. Garcia M., Mila N., Binefa G., et al. Fecal hemoglobin concentration as a measure of risk to tailor colorectal cancer screening: are we there yet. European Journal of Cancer Prevention 2015, 24:321-327.
15. Liao C.S., Lin Y.M., Chang H.C., et al. Application of quantitative estimates of fecal hemoglobin concentration for risk prediction of colorectal neoplasia. World Journal of Gastroenterology 2013, 19:8366-8372.
16. Auge J.M., Pellise M., Escudero J.M., et al. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program. Gastroenterology 2014, 147. 628-36.e1.
17. Yen A.M., Chen S.L., Chiu S.Y., et al. A new insight into fecal hemoglobin concentration-dependent predictor for colorectal neoplasia. International Journal of Cancer 2014, 135:1203-1212.
18. Wen C.P., David Cheng T.Y., Tsai S.P. Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians. Public Health Nutrition 2009, 12:497-506.
19. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
20. Fraser C.G., Allison J.E., Halloran S.P., et al. A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin. Journal of the National Cancer Institute 2012, 104:810-814.
21. Fraser C.G., Mathew C.M., McKay K., et al. Automated immunochemical quantitation of haemoglobin in faeces collected on cards for screening for colorectal cancer. Gut 2008, 57:1256-1260.
22. McLean M.H., Murray G.I., Stewart K.N., et al. The inflammatory microenvironment in colorectal neoplasia. PLoS ONE 2011, 6:e15366.
23. Potente M., Gerhardt H., Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell 2011, 146:873-887.
24. Haggar F.A., Boushey R.P. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clinics in Colon and Rectal Surgery 2009, 22:191-197.
25. Bhattacharya S., Bhattacharya S., Basu R., et al. Colorectal cancer: a study of risk factors in a tertiary care hospital of North Bengal. Journal of Clinical and Diagnostic Research 2014, 8:Fc08-Fc10.
26. Javid G., Zargar S.A., Rather S., et al. Incidence of colorectal cancer in Kashmir valley, India. Indian Journal of Gastroenterology 2011, 30:7-11.
27. Chao A., Thun M.J., Jacobs E.J., et al. Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. Journal of the National Cancer Institute 2000, 92:1888-1896.
28. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. American Journal of Clinical Nutrition 2007, 86:s836-s842.
29. Chiu H.M., Lee Y.C., Tu C.H., et al. Effects of metabolic syndrome and findings from baseline colonoscopies on occurrence of colorectal neoplasms. Clinical Gastroenterology and Hepatology 2015, 13. 1134-42.e8.